Shareholder Hong Zejun increased his holdings in Shenzhen Hepalink Pharmaceutical Group (09989) by 328,500 shares at a price of approximately HKD 3.99 per share.
On June 30, shareholder Hong Zejun increased his holdings in Hypera (09989) by 328,500 shares, with a price of 3.986 Hong Kong dollars per share, totaling approximately 1.3094 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on June 30th, shareholder Hong Zejun increased his holdings of Shenzhen Hepalink Pharmaceutical Group (09989) by 328,500 shares, at a price of 3.986 Hong Kong dollars per share, for a total amount of approximately 1.3094 million Hong Kong dollars. After the increase, the new total number of shares held is 24.28 million, with a shareholding percentage of 11.03%.
Related Articles
Anhui Conch Cement (00914) plans to acquire two cement assets for a maximum of 691 million yuan.
US Stock Market Move | AeroVironment (AVAV.US) rose nearly 10% in early trading after winning a $500 million contract from the US Department of Defense.
HANXBIO-B(03378) collaborates with TwinEdge Bioscience on AI drug research and development.
Anhui Conch Cement (00914) plans to acquire two cement assets for a maximum of 691 million yuan.
US Stock Market Move | AeroVironment (AVAV.US) rose nearly 10% in early trading after winning a $500 million contract from the US Department of Defense.
HANXBIO-B(03378) collaborates with TwinEdge Bioscience on AI drug research and development.
RECOMMEND
